BR112017017719A2 - imunoensaio homogêneo com compensação para sinal antecedente - Google Patents

imunoensaio homogêneo com compensação para sinal antecedente

Info

Publication number
BR112017017719A2
BR112017017719A2 BR112017017719A BR112017017719A BR112017017719A2 BR 112017017719 A2 BR112017017719 A2 BR 112017017719A2 BR 112017017719 A BR112017017719 A BR 112017017719A BR 112017017719 A BR112017017719 A BR 112017017719A BR 112017017719 A2 BR112017017719 A2 BR 112017017719A2
Authority
BR
Brazil
Prior art keywords
signal compensation
homogeneous immunoassay
antecedent
antecedent signal
reagents
Prior art date
Application number
BR112017017719A
Other languages
English (en)
Inventor
Wayne PATCH Daniel
Farace Giosi
Xie Hongzhi
V S N Yerramilli Murthy
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56689082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017017719(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of BR112017017719A2 publication Critical patent/BR112017017719A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01049—Glucose-6-phosphate dehydrogenase (1.1.1.49)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Abstract

imunoensaios homogêneos que permitem a compensação de sinais antecedentes inerentes em amostras e reagentes. o uso de imunoensaios homogêneos para a detecção da presença ou quantidade de arginina de dimetil simétrica (sdma) em amostras biológicas. reagentes e kits para conduzir os ensaios.
BR112017017719A 2015-02-20 2016-02-19 imunoensaio homogêneo com compensação para sinal antecedente BR112017017719A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562118832P 2015-02-20 2015-02-20
PCT/US2016/018667 WO2016134251A1 (en) 2015-02-20 2016-02-19 Homogenous immunoassay with compensation for background signal

Publications (1)

Publication Number Publication Date
BR112017017719A2 true BR112017017719A2 (pt) 2018-04-10

Family

ID=56689082

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017719A BR112017017719A2 (pt) 2015-02-20 2016-02-19 imunoensaio homogêneo com compensação para sinal antecedente

Country Status (16)

Country Link
US (2) US10775365B2 (pt)
EP (2) EP3259593B1 (pt)
JP (2) JP6896637B2 (pt)
KR (2) KR20230018536A (pt)
CN (2) CN107250795B (pt)
AR (1) AR103745A1 (pt)
AU (2) AU2016219847B2 (pt)
BR (1) BR112017017719A2 (pt)
CA (1) CA2977062A1 (pt)
ES (1) ES2936294T3 (pt)
FI (1) FI3259593T3 (pt)
HU (1) HUE060884T2 (pt)
MX (1) MX2017010505A (pt)
PL (1) PL3259593T3 (pt)
TW (1) TWI721966B (pt)
WO (1) WO2016134251A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3259593B1 (en) 2015-02-20 2022-10-05 IDEXX Laboratories, Inc. Homogenous immunoassay with compensation for background signal
EP3697499A4 (en) * 2017-10-19 2021-07-21 IDEXX Laboratories, Inc. DETECTION OF SYMMETRICAL DIMETHYLARGININE
US10745492B1 (en) 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US4341866A (en) * 1980-06-02 1982-07-27 Syva Company Antienzyme termination in enzyme immunoassays
DE3134787A1 (de) 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
IT1199088B (it) 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
US6461825B1 (en) * 1987-09-30 2002-10-08 Sanofi (Societe Anonyme) Immunometric assay kit and method applicable to whole cells
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
EP0399127A1 (en) * 1989-05-23 1990-11-28 Pharmacia ENI Diagnostics Inc. Homogeneous immunochemical method for determining haptens by means of ion selective electrodes
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) * 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5972703A (en) * 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US5804452A (en) 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
WO1998049199A1 (en) 1997-05-01 1998-11-05 Panorama Research, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
AU2452301A (en) 1999-12-22 2001-07-03 Research Foundation Of The State University Of New York, The Protein methylarginine-specific antibodies
WO2002004465A1 (en) 2000-07-06 2002-01-17 Fal Diagnostics Methods and kits for the detection of arginine compounds
US20040038296A1 (en) 2000-07-12 2004-02-26 Werner Naser Direct assessment of analyte to reference molecule ratios
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US6601006B2 (en) * 2000-12-22 2003-07-29 Idexx Laboratories, Inc. Methods for the calibration of analyte assays
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
FR2824825B1 (fr) * 2001-05-15 2005-05-06 Servier Lab Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
WO2004046314A2 (en) 2002-11-15 2004-06-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
US6991911B2 (en) 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US7813880B2 (en) 2004-03-25 2010-10-12 University Of Maryland, Baltimore Apparatus and method for providing optimal concentrations for medication infusions
CN1954214B (zh) 2004-03-30 2012-07-04 通用电气医疗集团生物科学公司 侧流格式、材料和方法
US7220842B2 (en) 2004-04-05 2007-05-22 Dade Behring Inc. Immunoassays for buprenorphine and norbuprenorphine
US20060046273A1 (en) * 2004-08-27 2006-03-02 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for oral fluid
ES2332218T3 (es) 2004-11-04 2010-01-29 Germediq Forschungs- Und Entwicklungsgesellschaft Mbh Metodo para la determinacion de arginina, argininas metiladas y sus derivados.
CA2495138C (en) * 2005-01-20 2012-10-23 Alison Jane Basile Multiplexed analysis for determining a serodiagnosis of viral infection
WO2006078813A2 (en) 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
US7723127B2 (en) 2005-03-03 2010-05-25 Novx Systems Inc. Immunoassay with extended dynamic range
CA2609702C (en) 2005-04-28 2013-05-28 Ventana Medical Systems, Inc. Antibody conjugates via heterobifunctional peg linkers
EP1946121A2 (en) 2005-10-27 2008-07-23 Yale University, Inc. Urinary proteomic biomarker patterns in preeclampsia
DE102005060057A1 (de) 2005-12-15 2007-06-28 Kellner, Karl-Heinz, Dr. Sandwich-Immunoassay für kleine Haptenmoleküle
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
WO2007103124A2 (en) * 2006-03-02 2007-09-13 Perkinelmer Las, Inc. Methods for distinguishing isomers using mass spectrometry
WO2008154457A1 (en) 2007-06-08 2008-12-18 Ark Diagnosties, Inc. Topiramate immunoassays
FR2919063B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
US8628936B2 (en) 2007-12-05 2014-01-14 King's College London Methods and compositions for multiplexed screening of disease
DK2313364T3 (da) 2008-08-07 2020-11-02 Idexx Lab Inc Fremgangsmåder til detektering af symmetrisk demethylarginin
US8168756B2 (en) 2008-10-24 2012-05-01 Ark Diagnostics, Inc. Levetiracetam immunoassays
CA2763948C (en) * 2009-06-02 2019-03-12 Biocrates Life Sciences Ag Combination of amino acids, acylcarnitines and biogenic amines for the assessment of chronic kidney disease
CN101587118B (zh) 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
CN101865911A (zh) 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
US8329424B2 (en) * 2010-06-25 2012-12-11 Siemens Healthcare Diagnostics Reduction in false results in assay measurements
WO2012065912A1 (de) 2010-11-17 2012-05-24 Karl-Heinz Kellner Automatenfähiger immunoassay für biogene amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
CN102154444B (zh) * 2010-12-30 2013-09-25 北京九强生物技术股份有限公司 测定不对称二甲基精氨酸浓度的方法及诊断试剂盒
US8394647B2 (en) 2011-02-17 2013-03-12 Siemens Healthcare Diagnostics Inc. Reducing non-covalently bound polysaccharide on supports
CN102628868B (zh) 2011-12-30 2014-09-17 北京九强生物技术股份有限公司 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒
EP2802869B1 (en) 2012-01-10 2018-03-07 IDEXX Laboratories, Inc. Immunoassay test slide
WO2013124478A1 (en) * 2012-02-24 2013-08-29 Universität des Saarlandes Symmetric dimethylarginine (sdma) modifies high density lipoprotein (hdl) to induce endothelial dysfunction
US9074482B2 (en) * 2012-04-24 2015-07-07 United Technologies Corporation Airfoil support method and apparatus
US20140038203A1 (en) 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
PT2888257T (pt) * 2012-08-21 2017-11-14 Janssen Pharmaceutica Nv Haptenos de quetiapina para utilização em ensaios imunológicos
US9970929B2 (en) 2013-01-18 2018-05-15 Ark Diagnostics, Inc. Voriconazole immunoassays
US9920136B2 (en) 2013-02-13 2018-03-20 Ark Diagnostics, Inc. Posaconazole immunoassays
DK3041576T3 (da) 2013-09-05 2019-09-09 Idexx Lab Inc Fremgangsmåder til at detektere nyresygdom
CN105793275B (zh) 2013-12-17 2020-02-21 西门子医疗保健诊断公司 多-半抗原突变型g6pdh缀合物的制备及其用于检测多种分析物的用途
EP3259593B1 (en) 2015-02-20 2022-10-05 IDEXX Laboratories, Inc. Homogenous immunoassay with compensation for background signal
EP3697499A4 (en) * 2017-10-19 2021-07-21 IDEXX Laboratories, Inc. DETECTION OF SYMMETRICAL DIMETHYLARGININE

Also Published As

Publication number Publication date
CA2977062A1 (en) 2016-08-25
KR102492243B1 (ko) 2023-01-25
EP3259593A1 (en) 2017-12-27
KR20170117574A (ko) 2017-10-23
AU2022204015A1 (en) 2022-06-30
CN107250795A (zh) 2017-10-13
JP2018507408A (ja) 2018-03-15
US11913942B2 (en) 2024-02-27
JP6896637B2 (ja) 2021-06-30
WO2016134251A1 (en) 2016-08-25
JP7459018B2 (ja) 2024-04-01
KR20230018536A (ko) 2023-02-07
EP3259593A4 (en) 2018-08-08
EP3259593B1 (en) 2022-10-05
EP4170346A1 (en) 2023-04-26
AU2016219847B2 (en) 2022-03-10
HUE060884T2 (hu) 2023-04-28
US20210018496A1 (en) 2021-01-21
US20160245801A1 (en) 2016-08-25
AR103745A1 (es) 2017-05-31
AU2016219847A1 (en) 2017-08-24
MX2017010505A (es) 2017-11-13
CN113699125A (zh) 2021-11-26
TWI721966B (zh) 2021-03-21
PL3259593T3 (pl) 2023-02-20
FI3259593T3 (fi) 2023-01-13
CN107250795B (zh) 2021-07-30
TW201643428A (zh) 2016-12-16
ES2936294T3 (es) 2023-03-15
US10775365B2 (en) 2020-09-15
JP2021156896A (ja) 2021-10-07

Similar Documents

Publication Publication Date Title
BR112016010106A2 (pt) ensaios para igfbp7 com melhor desempenho em amostras biológicas
BR112016002685A2 (pt) ensaios para timp2 que apresentam melhor desempenho em amostras biológicas
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
BR112017021256A2 (pt) dispositivos e métodos para a análise de amostras
BR112015023239A2 (pt) ensaio de combinação antígeno-anticorpo e métodos e composições para uso do mesmo
AU2018337650A1 (en) High dynamic range assays in hazardous contaminant testing
BR112016023418A8 (pt) método e kit para a quantificação de ovos de parasitas nas fezes
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
BR112017021686A2 (pt) método para detectar uma ou várias carbapenemases, dispositivo para detectar imunocromatográfico e uso do dispositivo para detectar imunocromatográfico
BR112012009291A2 (pt) sistema de reconhecimento de subenchimento para um biossensor
BR112018005812A2 (pt) ?método de imunoensaio para a detecção de um analito, kit de reagentes para detectar um analito por um imunoensaio e uso de um parceiro de ligação marcador-específico?
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
BR112015022844A2 (pt) métodos para detecção de anticorpos para doadores específicos e sistemas para pratica destes
BR112016007037A2 (pt) método para detectar câncer pancreático, anticorpo monoclonal e kit
ZA202002415B (en) Detection of symmetrical dimethylarginine
BR112017017719A2 (pt) imunoensaio homogêneo com compensação para sinal antecedente
BR112014020513A2 (pt) Métodos e sistemas para amplificação de sinal de bioensaios
BR112017011545A2 (pt) ensaio de desvio de mobilidade homogênea indireto para a detecção de produtos biológicos nas amostras do paciente
WO2014151290A3 (en) Assay for predictive biomarkers
BR112016017901A2 (pt) ensaio inovador para detectar periostina humana
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
BR112018013381A2 (pt) anticorpo especificamente ligante a antígenos derivados de miobacteria ou fragmento ligante a antígeno do mesmo
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]